What's the Latest in COVID-19?

"Breaking News" Updates

ezgif.com-webp-to-png

This activity is jointly provided by Global Education Group and Integritas Communications.

This activity is supported by an educational grant from AstraZeneca.

Program Overview

The presence of multiple new COVID-19 variants and subvariants has rapidly shifted strategies for treatment and prevention. Clinicians struggle to stay up to date with a rapidly changing field that has remained a public health concern, with shifting guidelines, Emergency Use Authorization status, and challenges with logistical implementation. This series of breaking news activities will discuss the latest news in COVID-19 variants, treatment guidelines, special populations, and any other news important to clinical practice. The series seeks to answer clinicians’ most important questions with up-to-date information.

Target Audience

The educational design of this activity addresses the needs of infectious disease specialists, internal medicine physicians, transplant specialists, oncologist, pharmacists, and other clinicians involved in managing patients who are at heightened risk for poor COVID-19 outcomes.

Activities

Activity 1 - EXPIRED

Novel COVID-19 Subvariants and the Changing Treatment Landscape: A COVID-19 "Breaking News" Update

Faculty Eric S. Daar, MD

Credits Maximum of 0.25 AMA PRA Category 1 Credit(s)™ and 0.25 AANP contact hour(s)

Expiration2023-12-23

Activity 2 - EXPIRED

Updates to Preventing and Treating COVID-19 in Immunocompromised Patients: Effect of XBB.1.5, BQ.1, and BQ.1.1 Subvariants: A COVID-19 "Breaking News" Update

Faculty Lewis W. Teperman, MD, FACS

Credits Maximum of 0.25 AMA PRA Category 1 Credit(s)™ and 0.25 AANP contact hour(s)

Expiration2024-01-27

Activity 3 - EXPIRED

Answers to Common Clinical Challenges in COVID-19: A COVID-19 "Breaking News" Update (Activity 3)

Faculty Elizabeth P. Clayborne, MD, MA

Credits Maximum of 0.25 AMA PRA Category 1 Credit(s)™ and 0.25 AANP contact hour(s)

Expiration2024-02-08

Activity 4

Anti-SARS-CoV-2 mAbs as Preexposure Prophylaxis: Proof of Concept and Future Directions - A COVID-19 "Breaking News" Update (Activity 4)

Faculty Raymund R. Razonable, MD, FIDSA, FAST

Credits Maximum of 0.25 AMA PRA Category 1 Credit(s)™ and 0.25 AANP contact hour(s)

Expiration2024-03-10

Activity 5

The End of the COVID-19 Public Health Emergency – What Does This Mean for Your Practice?: A Covid 19 "Breaking News" Update (Activity 5)

Faculty Leigh Lewis Speicher, MD, MPH

Credits Maximum of 0.25 AMA PRA Category 1 Credit(s)™ and 0.25 AANP contact hour(s)

Expiration2024-05-11

Activity 6

The Latest Data in Anti-SARS-COV-2 Monoclonal Antibodies: A COVID-19 "Breaking News" Update (Activity 6)

Faculty Roger J. Bedimo, MD

Credits Maximum of 0.25 AMA PRA Category 1 Credit(s)™ and 0.25 AANP contact hour(s)

Expiration2025-02-15